Skip to main content
. 2018 May 18;17(6):749–758. doi: 10.1080/15384101.2017.1421875

Figure 6.

Figure 6.

Chromosomes 7q14.1 and 14q11.2 focal deletions in blood and bone marrow samples from MYCN-amplified neuroblastoma patients predict poor survival. Kaplan Meier curve for overall survival in all patients with Chr7q14.1 deletion (A), Chr14q11.2 deletion (B) or both Chr7q14.1 and Chr14q11.2 deletions (C), and in MYCN-amplified neuroblastoma patients with focal deletions at both 7q14.1 and 14q11.2 (D).